Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Oracle may not be our future partner
Reply New Message
Prev Message Back To Forum Threaded View Next Message

From what I read the acquisition by Oracle is related to pharmaceutical trials ...

Crossflo/CDX as it concerns healthcare is hospital / patient records, etc. as a data sharing mechanism.

I still think it will be HP or IBM that will takeout PTSC/PDSG, but only when the patents are upheld (once again).

480 million shares x 2.00/share?

I'd sell, would you?

Hey I'm entitled to my dreams, right?

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply